The DCGI has accorded permission to conduct the Phase II-III clinical trial of Covaxin in the age group of two to 18-years-old to the Hyderabad based manufacturer Bharat Biotech International Ltd (BBIL). The trials will be conducted in 525 health volunteers
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy
